Medipharm Labs Corp (LABS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 09-2018 | 06-2018 | 03-2018 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 658 | 563 | N/A | N/A | N/A |
| Income taxes - deferred | 2,116 | 248 | N/A | N/A | N/A |
| Accounts receivable | -11,477 | -7,457 | N/A | N/A | -3 |
| Accounts payable and accrued liabilities | 14,161 | 21,040 | N/A | N/A | N/A |
| Other Working Capital | -17,625 | -549 | 21 | 4 | 24 |
| Other Operating Activity | 1,926 | -9,802 | -69 | -16 | -25 |
| Operating Cash Flow | $-10,241 | $4,043 | $-48 | $-11 | $-5 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | -32 | -76 | N/A | N/A | N/A |
| Other Investing Activity | -5,679 | -6,497 | 0 | 0 | 0 |
| Investing Cash Flow | $-5,711 | $-6,573 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 70,828 | 0 | 0 | 0 | N/A |
| Other Financing Activity | 9,396 | 3,087 | 0 | 0 | 0 |
| Financing Cash Flow | $80,224 | $3,087 | $0 | $0 | $N/A |
| Exchange Rate Effect | 51 | -7 | N/A | N/A | N/A |
| Beginning Cash Position | 8,400 | 7,850 | 509 | 520 | 362 |
| End Cash Position | 72,723 | 8,400 | 461 | 509 | 520 |
| Net Cash Flow | $64,272 | $557 | $-48 | $-11 | $158 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,241 | 4,043 | -48 | -11 | -5 |
| Capital Expenditure | -5,679 | -6,497 | N/A | N/A | N/A |
| Free Cash Flow | -15,920 | -2,454 | -48 | -11 | -5 |